Shandong Xinhua Pharmaceutical (000756.SZ) has obtained the registration certificate for the suspension of Oseltamivir phosphate and Oseltamivir.
Xinhua Pharmaceutical (000756.SZ) announced that the company recently received the "Drug Registration Certificate" for the approved issuance of oseltamivir phosphate granules for suspension (referred to as "this product" below) from the National Medical Products Administration. This product is used for the treatment of influenza A and B in patients aged 2 weeks and older (oseltamivir phosphate can effectively treat influenza A and B, but there is limited clinical data for the treatment of influenza B). Patients should use the product within 48 hours of the first symptoms appearing. This product can also be used for the prevention of influenza A and B in individuals aged 1 year and older.
Shandong Xinhua Pharmaceutical (000756.SZ) announced that it has recently received approval and issuance of the Drug Registration Certificate for the oseltamivir phosphate granules for suspension (referred to as "the product"). The product is used for the treatment of influenza A and B in patients aged 2 weeks and older (oseltamivir phosphate effective in treating influenza A and B, but there is limited clinical data for influenza B). Patients should use the product within 48 hours of the first symptom appearing. The product can also be used for the prevention of influenza A and B in individuals aged 1 year and older.
Related Articles
On December 23, DMALL (02586) spent HK$2.72 million to repurchase 285,000 shares.
Foshan Haitian Flavouring and Food (03288) will distribute a special dividend of 3 yuan per 10 shares on February 6, 2026.
Kuaishou-W (01024) spent HK$174 million on repurchasing 2.7176 million shares on December 23rd.
On December 23, DMALL (02586) spent HK$2.72 million to repurchase 285,000 shares.
Foshan Haitian Flavouring and Food (03288) will distribute a special dividend of 3 yuan per 10 shares on February 6, 2026.
Kuaishou-W (01024) spent HK$174 million on repurchasing 2.7176 million shares on December 23rd.
RECOMMEND
